|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.80 EUR | +2.57% |
|
+12.12% | +31.64% |
| 05-14 | Dermapharm hits highest level since August 2022 | DP |
| 05-14 | DERMAPHARM : Berenberg reaffirms its Buy rating | ZD |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Branded Pharmaceuticals | - | - | 537M | 588M | 629M | |||||
EBITDA | - | - | 229M | 259M | 281M | |||||
Branded Pharmaceuticals and Other Healthcare Products | 642M | 676M | - | - | - | |||||
EBITDA | 335M | 321M | - | - | - | |||||
Vitamins and Nutritional Supplements | ||||||||||
Other Healthcare Products | - | - | 402M | 387M | 364M | |||||
EBITDA | - | - | 57.8M | 56.48M | 53.4M | |||||
Pharmaceutical Product Distribution | ||||||||||
Parallel Import Business | 231M | 253M | 235M | 249M | 203M | |||||
EBITDA | 2.07M | 6.03M | -846K | -1.6M | -3.8M | |||||
Intersegment Revenues | - | - | - | - | - | |||||
Reconciliation/Group Holding Company | -1.48M | -2.84M | -39.91M | -43.41M | -31.45M | |||||
EBITDA | -6.76M | -7.51M | -5.63M | -5.36M | -5.9M | |||||
Medicinal Chemicals and Botanical Products | ||||||||||
Herbal Extracts | 72.04M | 98.09M | - | - | - | |||||
EBITDA | 24.55M | 12.18M | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Germany | 787M | 854M | 707M | 726M | 696M | |||||
Total Assets | - | - | - | - | 558M | |||||
France | - | - | 152M | 139M | 138M | |||||
Total Assets | - | - | - | - | 607M | |||||
Spain | 75.29M | 78.02M | 118M | 118M | 119M | |||||
Total Assets | - | - | - | - | 209M | |||||
Others | - | - | 89.75M | 104M | 117M | |||||
Total Assets | - | - | - | - | 43.78M | |||||
Austria/Switzerland | 42.19M | 43.21M | 68.57M | 94.86M | 95.1M | |||||
Total Assets | - | - | - | - | 65.54M | |||||
Eastern Europe | 38.78M | 49.96M | - | - | - | |||||
Total Assets | - | - | - | - | - |
- Stock Market
- Equities
- DMP Stock
- Financials Dermapharm Holding SE
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition